Baidu
map

Ann Intern Med:公共报告的死亡率对现状的改善幅度有限

2016-05-31 Mechront 译 MedSci原创

发表在Annals of Internal Medicine的研究表明,医保医院比较计划中公共报告的死亡率并不能改善三种常见疾病的死亡率。研究人员研究了2000万多个医疗保险受益人,所有参与者子啊2005-2012年被录取到医院参加医疗保险的公共报告计划。比较了只有过程指标报告期间(2005–2007)和死亡率报告期间(2008–2012)的心肌梗死、心脏衰竭、肺炎的30天死亡率。数据显示,两个期

发表在Annals of Internal Medicine的研究表明,医保医院比较计划中公共报告的死亡率并不能改善三种常见疾病的死亡率。

研究人员研究了2000万多个医疗保险受益人,所有参与者子啊2005-2012年被录取到医院参加医疗保险的公共报告计划。比较了只有过程指标报告期间(2005–2007)和死亡率报告期间(2008–2012)的心肌梗死、心脏衰竭、肺炎的30天死亡率。

数据显示,两个期间每季度死亡率下降幅度分别为0.23%和0.09%(每季度改变0.13%,95% CI, 0.12%~ 0.14%)。非报告疾病的死亡率在两个期间每季度分别下降0.17%和0.11%(每季度改变0.06%,CI, 0.05%~ 0.07%)。

研究人员发现,尽管在研究期间随着时间,所有三种疾病的死亡率均下降,但死亡率报告期间死亡率下降更慢。

研究结果表明,公共报告的死亡率对现状的改善幅度有限。

原始出处:

Karen E. Joynt, E. John Orav, et al.Public Reporting of Mortality Rates for Hospitalized Medicare Patients and Trends in Mortality for Reported Conditions .Ann Intern Med. Published online 31 May 2016 doi:10.7326/M15-1462

Public Reporting Not Associated with Reduced Mortality Rates .NEJM Journal Watch.May 31, 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=130320, encodeId=33e5130320c0, content=不错哦继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 18 15:36:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606933, encodeId=cf58160693359, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jun 02 06:42:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88080, encodeId=99608808054, content=多学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 15:46:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87992, encodeId=83598e99253, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Jun 01 07:46:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87851, encodeId=21f08e851a8, content=死亡好可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=7af91730839, createdName=足球疯子, createdTime=Tue May 31 20:42:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-09-18 1e10c84am36(暂无匿称)

    不错哦继续关注

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=130320, encodeId=33e5130320c0, content=不错哦继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 18 15:36:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606933, encodeId=cf58160693359, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jun 02 06:42:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88080, encodeId=99608808054, content=多学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 15:46:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87992, encodeId=83598e99253, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Jun 01 07:46:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87851, encodeId=21f08e851a8, content=死亡好可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=7af91730839, createdName=足球疯子, createdTime=Tue May 31 20:42:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=130320, encodeId=33e5130320c0, content=不错哦继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 18 15:36:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606933, encodeId=cf58160693359, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jun 02 06:42:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88080, encodeId=99608808054, content=多学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 15:46:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87992, encodeId=83598e99253, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Jun 01 07:46:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87851, encodeId=21f08e851a8, content=死亡好可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=7af91730839, createdName=足球疯子, createdTime=Tue May 31 20:42:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-06-01 沉心多思

    多学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=130320, encodeId=33e5130320c0, content=不错哦继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 18 15:36:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606933, encodeId=cf58160693359, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jun 02 06:42:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88080, encodeId=99608808054, content=多学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 15:46:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87992, encodeId=83598e99253, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Jun 01 07:46:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87851, encodeId=21f08e851a8, content=死亡好可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=7af91730839, createdName=足球疯子, createdTime=Tue May 31 20:42:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-06-01 1dd8c52fm63(暂无匿称)

    了解一下!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=130320, encodeId=33e5130320c0, content=不错哦继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 18 15:36:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606933, encodeId=cf58160693359, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jun 02 06:42:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88080, encodeId=99608808054, content=多学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 15:46:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87992, encodeId=83598e99253, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Jun 01 07:46:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87851, encodeId=21f08e851a8, content=死亡好可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=7af91730839, createdName=足球疯子, createdTime=Tue May 31 20:42:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-05-31 足球疯子

    死亡好可怕

    0

相关资讯

BMJ:5-50岁体型的变化轨迹可预测机体的死亡率

BMJ:5-50岁体型的变化轨迹可预测机体的死亡率本研究旨在评估早期和中期的体型变化轨迹与死亡风险之间的关系。采用前瞻性队列研究设计,共纳入了80266名女性和36622名男性。所有研究人员回忆5岁、10岁、20岁、30岁和 40岁时的体型,并提供50岁时的身体质量指数,从60岁时开始随访,中位死亡时间为15-16年。主要评估结果为全因死亡和病因特异性死亡率。研究人员确定了5-50岁的5个不同的体

BMJ研究新闻:低出生体重与婴儿及青少年时期较高的死亡率有关

BMJ研究新闻:低出生体重与婴儿及青少年时期较高的死亡率有关来自卡蒂夫大学的一项新的研究表明,低出生体重与婴儿期、儿童期及青春期死亡率的增加有关,该研究结果强调了女性孕前健康的重要性。研究人员随访了1993年1月1日至2011年12月31日出生的所有活产婴儿。最后共纳入了12355251名婴儿,根据出生体重进行分类,极低出生体重儿是指体重在500-1499g(139608名)的婴儿,低出生体重儿的

BMJ:探究脓毒症患者晚期死亡原因

BMJ:探究脓毒症患者晚期死亡原因本研究旨在确定脓毒症患者晚期死亡是否主要是由于预先存在的并发症所致,还是由于脓毒症本身所致。采用观察性研究设计,950名年龄≥65岁(1998-2010)脓毒症患者接受住院治疗,均有医疗保险。匹配了777名成年患者目前已出院,788名非脓毒症感染患者,504名急性无菌性炎症性疾病患者。主要研究结果为不同时间间隔的晚期(31天到2年)死亡率和死亡几率。结果发现,非

Diabetes Care:糖尿病发病时越年轻,死亡率越高

该研究比较了354例在15-30岁之间(T2DM15-30)被诊断为T2DM的患者并发症的患病率,并匹配了在40-50岁(T2DM40-50)之间被诊断为T2DM的1062例患者。还在覆盖更大范围的发病年龄的15238例患者中,根据其发病年龄检测了标准化死亡率比(SMRs)。研究人员根据一个标准化协议,对并发症状态进行了评估,并从电子数据库中提取数据。生存状态通过链接到澳大利亚国家死亡指数数据进行

JAMA Surgery:7大急诊手术的死亡率和并发症发生率分析

研究人员对42176例手术进行的一项回顾性研究显示,有7类紧急手术(EGS)在所由紧急手术中占较大比例(80.0%),发生死亡(80.3%)和并发症(78.9%)的几率较高,且病人花销较大(80.2%)。这7类手术为部分结肠切除术、小肠切除术、胆囊切除术、消化性溃疡的手术处理、腹膜粘连剥离术、阑尾切除术和剖腹探查术。 研究人员指出,接受EGS手术的患者出现死亡的风险是采取相同术式但为择期手术的患者

BMJ:抗生素耐药性所导致的不良影响将超过医疗对寿命的改善

BMJ研究新闻:抗生素耐药性感染所致的死亡人数正不断增加据抗菌素耐药性的报道显示,在美国和欧洲每年有50000人死于抗生素耐药性感染,且在未来十年这一人数可能还会增加。英国精算师协会发表的Longevity Bulletin on Antimicrobial Resistance分析了当前抗生素耐药性的趋势对未来10年英国及OECD国家人们预期寿命的影响。原始出处:Susan Mayor. Inc

Baidu
map
Baidu
map
Baidu
map